Compelling evidence that if clinical trialists interested in the impact of treatment on health-related #qualityoflife include only generic measures & fail to include responsive & valid disease-specific measures in their #RCTs, they risk missing the crucial signal.
pubmed.ncbi.nlm...
pubmed.ncbi.nlm...
